June 16, 2023 07:03 AM EDTUpdated 03:06 PM
Peer Review

Ex-Metacrine chief Pre­ston Klassen recharges at mi­croR­NA biotech; Al­lo­gene be­gins search for a CFO

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Pre­ston Klassen has mapped out his next des­ti­na­tion as pres­i­dent and R&D chief of mi­croR­NA de­vel­op­er Reg­u­lus Ther­a­peu­tics. Klassen was …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times